Niagen Bioscience (NAGE) Change in Account Payables (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Change in Account Payables data on file, last reported at $2.5 million in Q1 2026.

• Change in Account Payables for Q1 2026 came in at $2.5 million, up 17.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 21.56% YoY), and the FY2025 annual result was $2.3 million, up 312.75% from the prior year.
• Change in Account Payables rose to $2.5 million in Q1 2026 per NAGE's latest filing, from -$1.9 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $3.0 million in Q2 2025 and troughed at -$2.3 million in Q1 2024.
• A 5-year average of $205470.6 and a median of $206000.0 in 2024 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2022 and 2025: Change in Account Payables tumbled 229.26% in 2022, then soared 1379.61% in 2025.
• A 5-year view of Change in Account Payables shows it stood at $560000.0 in 2022, then jumped by 84.64% to $1.0 million in 2023, then surged by 118.76% to $2.3 million in 2024, then plunged by 186.03% to -$1.9 million in 2025, then jumped by 227.49% to $2.5 million in 2026.
• Business Quant data shows NAGE's Change in Account Payables at $2.5 million in Q1 2026, -$1.9 million in Q4 2025, and -$938000.0 in Q3 2025.